Piyush Patel, profile picture
Uploaded byPiyush Patel
515 views

Drug Delivery Systems Americas (2011) Pp

The two-day Drug Delivery Systems Americas conference in Boston will focus on the latest scientific research, manufacturing, and commercial opportunities in drug delivery systems. Key topics will include drug formulations for small molecules, proteins, peptides, and biologics; delivery technologies such as controlled release, nanotechnology, and biologics targeting; commercialization aspects including partnering, outsourcing, and regulations; and case studies. Over 20 industry leaders from companies including Novartis, Pfizer, Genzyme, and Abbott will present on challenges and innovations in developing advanced drug delivery technologies. Attendees will gain insights on enhancing bioavailability, managing product lifecycles, and identifying strategic partnerships in the growing field of drug delivery.

Embed presentation

Downloaded 11 times
CALL NOW FOR EARLY BIRD Drug Delivery Systems DISCOUNTS Americas 2011 Examining latest scientific research, manufacturing and commercial opportunities November 16th - 17th 2011, Boston, USA BOOK NOW! Key Speakers Anand Subramony, Principal Fellow & Head Novel Delivery Technologies & Therapeutics, Novartis Avinash G. Thombre, Research Fellow, Pfizer Bernhardt L. Trout, Director, Novartis-MIT Center for Continuous Manufacturing Danchen Gao, Director of Intellectual Property Strategy, Abbott Joseph Wong, Principal Scientist, Baxter Kathleen L. Hefferon, Professor, University of Toronto Lee Shorter, Director R&D Open Innovation, GlaxoSmithKline Niren Murthy, Associate Professor, Georgia Institute of Technology Oliver Steinbach, Senior Director, Head Bio-Molecular Engineering, Philips Corporate Technologies Otilia Koo, Senior Research Investigator, Drug Product Science & Technology, Bristol-Myers Squibb Peter Hoffmann, VP New Technology Development, Genzyme Riccardo Panicucci, Head of Chemical & Pharmaceutical Profiling, Novartis Saileta Prabhu, Scientist, Genetech Z. Jane Li, Senior. Research Fellow, Boehringer-Ingelheim Driving the Industry Forward | www.futurepharmaus.com Media Partners Organised By To Book Call: +44 (0) 20 7336 6100 | www.visiongain.com/ddsamericas
Conference Introduction Drug Delivery Systems Americas November 16th - 17th 2011, Boston, USA Dear Colleague, orth $93.60bn in 20091, drug delivery technology and systems is one W Poster Presentation of the fastest growing markets in the pharmaceutical and biotechnology At a busy conference it is hard to make sure everyone who shares your interests knows what you are doing. sectors with almost 50% of the revenue generated from North America . 2 Maximise your time at Visiongain’s Biosimilars and Follow- This sector is expected to maintain double digit growth in the coming years On Biologics Americas meeting by sharing your results in a poster presentation. With a plethora of key decision makers, which will depend on new and innovative developments in drug delivery take advantage of this senior networking opportunity. technology that offer improved clinical advantages, patient comfort, Please send your 200 word abstract, in English, to: convenience and compliance. info@visiongainglobal.com for approval. The deadline for submissions is Friday, November 4th, 2011. Please rug Delivery Systems Americas 2011 - building on the success of our D include contact details for the corresponding author(s). previous six drug delivery conferences will bring together industry experts Academic institutions will not be charged a fee if booked as full-price delegates. Posters submitted by pharmaceutical from around the world to discuss the crucial issues and current trends and biotechnology firms will be charged a fee of £199 in drug delivery systems. This two day event will focus on various drug (USD $319*). formulations, delivery of lipids, proteins and peptides additionally exploring Posters submitted by service providers / vendors are welcome and will be subject to evaluation. Upon approval drug delivery commercial aspects, partnering and out-sourcing, key a fee of £500 (USD $801*) will apply. Two delegates from your organisation must be booked at full price to present regulatory and legal issues. a poster. Please note that all posters will be displayed at the Attendance at this conference will enable you to: discretion of Visiongain Ltd and are subject to approval. Due to limited space, please register your interest early. • vercome challenges and opportunities in the delivery of small molecules O • ain insight about protein and peptide drug delivery strategies for product G lifecycle management Who should attend this conference? • xplore innovations in generic development of drug delivery systems E VPs, Directors, Heads, Managers of: • Pharmaceutical Development • Discuss about enhancing the bioavailability of poorly soluble drugs • Drug Delivery • Delivery Device Development • Learn impact on product lifecycles: controlled-release technologies • Product Development • Analytical Chemistry • Evaluate niosomes as effective transdermal drug delivery systems • Pre-formulation • Project Management • Discover advances in oral transmucosal drug delivery • Technology Development • Drug Delivery Partnering • Stay ahead by learning latest on biologics delivery systems • Out-sourcing • In-Licensing • Identify different strategies in managing a drug delivery alliance • Technology Assessment • Lifecycle management • Examine PTD–DRBD siRNA Delivery • Strategic Planning and Development • Formulation/Stability • Obtain latest information on ultrasonic drug delivery • Business Development • Licensing • Create patient centered drug delivery product • Commercial Development • Patents • ind out information on regulations and current practices nasal drug products F • Lifecycle Management • Strategic Planning and Development • eview advanced technological and regulatory developments on QbD/PAT R • Financial Analyst in Pharmaceutical development • Pharmaceutical and Analytical R&D • Testing • revent aggregation in manufacturing and formulation of protein and P • New Product Planning • New Technology Evaluation peptide therapeutics • Marketing • Brand Management • btain the latest market analysis, and meet manufacturers showcasing O • Product Management • Sales their leading products • Regulatory Affairs I look forward to meeting you at the conference Others: • Intellectual Property Attorneys Best regards • Venture Capitalists • Medical Device Companies • Analysts/Investment Banks • CROs • Contract Sales Organisations • Universities and Government Research • Testing and Manufacturing Equipment Sonia Tomar • Packaging Companies Conference Producer *USD price is estimate only 1 visiongain’s Drug Delivery technologies: Commercial prospects 2010-2025 2 MarketsandMarkets: Top 10 Drug Delivery Technologies Market to be US$156 Billion by 2015
Day 1 Drug Delivery Systems Americas Wednesday November 16th 2011 09:00 Registration and refreshments 14:20 Life-cycle management: development and manufacturing process considerations for fixed-dose 09:30 Opening address from the chair combination drug products • aterial powder and mechanical properties considerations that impact M 09:40 The magic bullets of the shots heard round the the processibility and quantity of fixed-dose combination products world targeted macromolecule delivery • echnologies to monitor process and product quality, as well as to T • Obtain overview of the option to deliver biologics to target manage risks • Stimulate use advanced drug delivery formulation for targeting • ontrol systems that can improve scale-up and manufacturing C • Enable macromolecules targeting to treat • Identify state of the art targeting delivery options Otilia Koo Senior Research Investigator, Drug Product Science & Technology Peter Hoffmann Bristol-Myers Squibb VP New Technology Development Genzyme Pharmaceuticals 15:00 Afternoon Refreshments 10:20 Emerging drug delivery technologies towards patient centric therapy 15:20 The mucosal response to plant-derived • Delivery of high volume biologics/antibodies: biopharmaceuticals • atch pumps devices as an emerging alternative to subcutaneous P • iopharmaceuticals can be produced quickly and inexpensively in plants B injections for the delivery of biologics • onsumption of vaccines proteins via edible plant tissues has been C • Use of mechanical and electromechanical systems demonstrated to effectively elicit a mucosal immune response • Creating patient centric drug delivery tools via user studies • lants have advantages as bioreactors because unlike bacterial systems, P • Microneedles and the trandermal interface they possess post-translational machinery, and unlike mammalian cell • Programmable drug delivery methods culture systems, they are free from infectious contaminants Anand Subramony Principal Fellow and Head • lant-derived biopharmaceuticals have enormous potential for assisting P Novartis vaccination programs in developing countries, for the prevention of global pandemics/ bioterrorism, and for applications in personalized medicine 11:00 Morning refreshments • number of plant derived biopharmaceuticals have completed clinical A trials and have now entered the global marketplace 11:20 Overcome challenges and opportunities in the Kathleen L. Hefferon Professor delivery of small molecules University of Toronto • Fundamentals of delivery of small molecules • Controlled release in delivery of proteins and nucleic acids • nalysing intestinal solubility and permeability and particle size to A 16:00 Addressing delivery of antibodies across the blood- overcome rate limited absorption brain barrier (BBB) Z. Jane Li • Overview of the transport barriers for antibodies in the brain Senior Research Fellow • Disposition of antibodies in the CNS Boehringer-Ingelheim • Leveraging receptor-mediated transcytosis for CNS delivery 12:00 Development and administration of intravenous Saileta Prabhu Scientist nanosuspension Genetech • here has been growing interest in nanoparticles as an approach to T formulate poorly soluble drugs • his presentation provides an insight into various challenges associated with T 16:40 Closing remarks from the chair developing and administrating intravenous nanosuspension including: • formulation approach of stabilizing nanosuspension A 16:50 Networking Drinks • article size and nanosuspension sterility considerations P Take your discussions further and build new • re-clinical disposition of a nanosuspension following IV administration P relationships in a relaxed and informal setting. • nfusion rates for nanosuspension I Joseph Wong Principal Scientist Baxter N EW Pharma Business Daily SL 12:40 Networking lunch E Each issue of Pharma Business Daily newsletter focuses on latest TT ER breaking stories in your market. Delivered directly to your Inbox or 13:40 Life cycle management through drug available through the website, all the industry news is available to delivery technologies you all the time. When you want the news its there for you - it really is that simple. Over 25+ stories everyday as they happen. Never again • Challenges and opportunities in life cycle management will any of your colleagues be aware of news that you aren’t. Plus • Product enhancement using drug delivery exclusive features from visiongain conferences and in-depth analysis • Platform controlled release technologies from visiongain analysts will be available to you thanks to your • Case studies and lessons learned subscription to PharmaBusinessDaily. This information is not available Avinash G. Thombre anywhere else. Research Fellow Call +44 (0)207 336 6100 or visit www.visiongain.com to sign up. Pfizer Due to unforeseen circumstances the programme may change and visiongain reserves the right to alter the venue and/or speakers c Copyright visiongain Ltd, 2011
Day 2 Drug Delivery Systems Americas Thursday November 17th 2011 09:00 Registration and refreshments 12:40 Networking lunch 09:30 Opening address from the chair 13:40 Prevent aggregation in manufacturing and formula- tion of protein and peptide therapeutics • Techniques to predict aggregation propensity 09:40 New materials for drug delivery and • New approaches to preventing aggregation molecular imaging • A strategy for developability and manufacturability early on • Overview on new materials for drug delivery • Ways to design molecules for stability • Autocatalytic drug delivery vehincles Bernhardt L. Trout • Polyketals : a new biomaterial for drug delivery Director, Novartis-MIT Center for Continuous Manufacturing • Oral siRNA delivery vehicles Professor, Department of Chemical Engineering, Massachusetts Institute of Technology Niren Murthy Associate Professor Georgia Institute of Technology 14:10 Finding synergy in drug delivery through strategic outsourcing 10:20 IMAG(IN)E global - release local – Image-guided • The value of strategic outsourcing: decision drivers ultra sound-triggered drug delivery • From transactional to strategic • edical imaging technologies are becoming an integral part of M • Strategic outsourcing: what lies ahead therapeutic interventions Danchen Gao • he development of ultrasound techniques that could non-invasively T Director of Intellectual Property Strategy trigger the delivery of also very new drug formats such as RNAi Abbott therapeutics at a targeted location opens up exciting possibilities for advancing personalized medicine • key success factor for the effective translation of new drug delivery A 15:00 Afternoon refreshments concepts into clinical practice are partnerships with leading academic, medical institutions and industrial partners • hilips’ image-guided ultrasound-mediated drug delivery platform offers P 15:20 Open Innovation in preclinical development at researchers a unique approach to investigating the delivery of various GSK pharmaceuticals therapeutic molecules and capitalizes upon Philips’ existing expertise in medical imaging technologies for diagnosis, therapy planning and • What is open innovation? minimally-invasive medical procedures • hy is GSK using open innovation within the platform technology and W • e show advances in temperature sensitive liposomes with incorporated W Science group? drugs and MRI-imaging labels as well as pressure-sensitive microbubbles • Process GSK PTS is following for open innovation with specific ultrasound-imaging and drug release characteristics for the • Examples of successful open innovation collaborations local delivery of small molecule- and nucleic-acid based therapeutics including siRNA • How will success of open innovation be measured? Oliver Steinbach Lee Shorter Senior Director, Head Bio-Molecular Engineering Director R&D Open Innovation Philips Corporate Technologies GlaxoSmithKline 11:00 Morning refreshments 16:00 Patent and other Intellectual property rights in drug delivery • Advancements in drug delivery technology 11:20 Sponsor Spotlight Session • Patenting the technological advancements T ake this unique opportunity to be a part of the conference • Issues around manufacturing process patents theme, network, share ideas and provide an overview of your • ntellectual property protection, such as trade secrets, copyrights, I product/services to the audience. For more information please and trademarks contact damian.gorman@visiongainglobal.com 16:40 Chair’s closing remarks 12:00 Presentation to be announced Riccardo Panicucci Head of Chemical & Pharmaceutical Profiling 16:50 End of Conference Novartis
Partners Drug Delivery Systems Americas November 16th - 17th 2011, Boston, USA Media Partners: PharmiWeb.com is the leading industry-sponsored Sponsorship and exhibition opportunities: portal for the pharmaceutical sector. Supported This event offers a unique opportunity to meet and do business by most of the leading pharmaceutical corporations, PharmiWeb. with some of the key players in the pharmaceutical and biotech com provides dynamic real-time news, features, events listings and international jobs to industry professionals across Europe and the US. industries. If you have a service or product to promote, you can For further information please email: corporate@pharmiweb.com do so at this event by: • Hosting a networking drinks reception BIOTECHNOLOGY EUROPE is owned by • Taking an exhibition space at the conference BIOTECHNOLOGY WORLD. It is based and located in Warsaw, Poland. Biotechnology World was founded in 2007 to • Advertising in the delegate documentation pack provide the world’s biotech and pharma information and market to • Providing branded bags, pens, gifts, etc. make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the If you would like more information on the range of BIOTECHNOLOGY EUROPE platform that will allow a quick spread of sponsorship or exhibition possibilities for visiongain's information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and Drug Delivery Systems Americas Conference, marketing solutions. One of the mains goals of BIOTECHNOLOGY please contact us. EUROPE is to integrate the Biotech and Pharma Sector in Europe to Damian Gorman, +44 (0)20 7549 9934 global biotechnology, pharmaceutical and life science activities. For further information please visit www.biotechnology-europe.com damian.gorman@visiongainglobal.com InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, jobs and events and is home to InPharmjobs.com, Pharmafile and About visiongain: Pharmafocus. Visiongain is a specialist business information company focused on For further information please visit: www.inpharm.com providing cutting edge products and services across the Pharmaceutical/ Biotech, Telecommunications, Defence and Finance sectors, which Future Pharmaceuticals has forged powerful Driving the Industry Forward | www.futurepharmaus.com include reports, conferences, online daily news and offline news relationships with key industry leaders to provide analysis and bespoke consultancy. With a commitment to innovation a platform for successful brand recognition, and for senior decision- and excellence, visiongain offers flexible solutions to meet our clients’ makers to have the means to procure and plan implementation business intelligence needs, providing the right information at the strategies based on the topics covered. Positioned to be an authoritative resource within top pharma companies as well as small, right time to facilitate the commercial decision-making process. Our specialty, and biotech, Future Pharmaceuticals magazine is geared pharmaceutical products include Pharma Business Daily, the leading to create a deep penetration into a highly targeted and responsive daily email newsletter for the pharmaceutical, biotech and healthcare audience, bridging the gap between the industries’ top issues and industries, and a range of independent, high-quality, in-depth reports the solutions top-tier vendors can provide. covering focused and topical areas of concern. Our pharmaceutical For further information please visit: www.futurepharmaus.com conferences address the hottest commercial, regulatory and technical topics and provide an ideal forum for debate and networking for pharmaceutical professionals from around the world. For further information, please visit: www.visiongain.com
Registration Form Drug Delivery Systems Americas November 16th - 17th 2011, Boston, USA Conf. code PP Standard Prices Conference only Fee: £1299 (USD* 2081) Drug Delivery Systems Americas November 16th - 17th 2011 Number of bookings: Total cost: Boston, USA *USD price is estimate only Promotional Literature Distribution Distribution of your company’s promotional literature to all conference attendees Fee: £999 VAT: £199.80 Total: £1198.80 How to book Details Email: piyush.patel@visiongain.com Forename: Surname: Web: http://www.visiongain.com/ddsamericas UK Office: Job Title: Company: Tel: +44(0) 20 7549 9961 Fax: +44(0) 20 7549 9932 Main Switchboard Number: Visiongain Ltd 230 City Road London Address: EC1V 2QY UK General information Venue: TBA, Boston, USA Country: Postcode: Payment terms: Visiongain require the full amount to be paid before the conference. Visiongain Ltd may refuse entry to delegates who have not paid their invoice in full. A credit card guarantee Phone: Fax: may be requested if payment has not been received in full before the event. Visiongain Ltd reserves the right to charge interest on unpaid invoices. Email: Substitutions/name changes or cancellations: There is a 50% liability on all bookings once made, whether by post, fax, email or web. There is a no refund policy for cancellations received on or Signature: after one month before the start of the event. Should you decide to cancel after this date, the full invoice must be paid. Conference notes will then be sent to you. Unfortunately, we are unable to transfer places I confirm that I have read and agree to the terms and conditions of booking between conferences. However, if you cannot attend the conference, you may make a substitution/name change at any time, as long as we are informed in writing by email, fax or post. Name changes and substitutions must be from the same company or organisation and are not transferable between Methods of payment countries. Please note that discounted delegates places at a visiongain event are non refundable. Payment must be made in sterling Invoice alterations: There will be an administration charge of £50 for any changes to an invoice, excluding substitutions/name changes, requested by the customer. This will be charged to the By Mail: Complete and return your signed registration form together with your cheque payable customer by credit card prior to the changes being made. to Visiongain Ltd and send to: visiongain Ltd, BSG House, 226-236 City Road, London, EC1V 2QY, UK Indemnity: Visiongain Ltd reserves the right to make alterations to the conference/executive briefing content, timing, speakers or venue without notice. The event may be postponed or cancelled By Fax: Complete and fax your signed registration form with your credit card details due to unforeseen events beyond the control of visiongain Ltd. If such a situation arises, we will try to +44 (0) 20 7549 9932 to reschedule the event. However, visiongain Ltd cannot be held responsible for any cost, damage or expenses, which may be incurred by the customer as a consequence of the event being postponed or By Phone: Call us on +44 (0) 20 7336 6100 with your credit card details cancelled. We therefore strongly advise all our conference clients to take out insurance to cover the cost of the registration, travel and expenses. By Credit Card: Fill in your card details below and fax back to +44 (0) 20 7549 9932 Data Protection: Visiongain Ltd gathers and manages data in accordance with the Data By Bank Transfer: Protection Act 1988. Your personal information contained in this form may be used to update you on visiongain Ltd products and services via post, telephone, fax or email, unless you state otherwise. We Visiongain Ltd A/C: visiongain Ltd may also share your data with external companies offering complementary products or services. If you Barclays Bank Sort Code: 20-71-64 wish for your details to be amended, suppressed or not passed on to any external third party, please Piccadilly Branch Account No: 6038 7118 send your request to the Database Manager, visiongain Ltd, BSG House, 226-236 City Road, London, EC1V 2QY. Alternatively, you can visit our website at www.visiongain.com and amend your details. 48 Regent Street Swift Code: BARC GB22 Please allow approximately 30 days for your removal or update request to be applied to our database. London W1B 5RA, UK IBAN: GB80 BARC 20716460387118 Following your removal or update request, you may receive additional pieces of communication from visiongain Ltd during the transitional period, whilst the changes are coming into effect. Please debit my credit card: Fee: The conference fee includes lunch, refreshments and conference papers provided on the day. Access MasterCard Visa American Express This fee does not include travel, hotel accommodation, transfers or insurance, (which we strongly recommend you obtain). VAT: VAT will be charged at the local rate on each conference. Delegates may be able to recover VAT Card number: incurred by contacting Eurocash Corporation plc +44 (0) 1273 325000, eurocash@eurocashvat.com. Eurocash specialise in recovering cross-border VAT. How we will contact you: Visiongain Ltd’s preferred method of communication is by email and phone. Please ensure that you complete the registration form in full so that we can contact you. Expiry Date: Unable to attend Security number (last 3 digits on back of credit card): Obviously nothing compares to being there but you need not miss out. Simply tick the box and send with your payment. You will receive speaker talks in PDFs two weeks after the event. Signature: Yes, please send me speaker talks Price£550 VAT:£110 Total:£660 Cardholder’s name: Office use only News updates Please tick if you do not want to receive email news updates in the future www.visiongain.com/ddsamericas

More Related Content

PDF
2nd prefilled syringes americas (2011)
byPranita Nangia
 
PDF
P 056 Pre Filled Syringes
bykprior88
 
PDF
Driving Innovation In Bio Pharma W Plm
byJenna Dudevoir
 
PPT
PDA Annual Mtg 2012 - CAACB Talk
bymewiebe
 
PDF
Controlled Release conference, London, 30th-31st March
bysbryant89
 
PPTX
Gluco Sentient Final NSF I-Corps presentation
byStanford University
 
PDF
Single Use Bioreactors (2012)
byshad121
 
PDF
4th Pre Filled Syringes (2011) Pp
byPiyush Patel
 
2nd prefilled syringes americas (2011)
byPranita Nangia
 
P 056 Pre Filled Syringes
bykprior88
 
Driving Innovation In Bio Pharma W Plm
byJenna Dudevoir
 
PDA Annual Mtg 2012 - CAACB Talk
bymewiebe
 
Controlled Release conference, London, 30th-31st March
bysbryant89
 
Gluco Sentient Final NSF I-Corps presentation
byStanford University
 
Single Use Bioreactors (2012)
byshad121
 
4th Pre Filled Syringes (2011) Pp
byPiyush Patel
 

What's hot

PPTX
Affinity NSF Final Presentation
byStanford University
 
PDF
Bio g - ManufacturingIintelligence webinar GBX
byGBX Summits
 
PDF
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
byfinance40
 
PDF
C ph i biosimilar presentation - rahul padhye - reliance
byGenericlicensing.com
 
PPTX
Ground Flour Pharma final NSF I-Corps presentation
byStanford University
 
PDF
"10th Contract Manufacturing for Pharmaceuticals and Biotech Conference
bycassie111
 
PDF
luxe research presentation at InnoCos Europe, Paris
byKGS Global
 
Affinity NSF Final Presentation
byStanford University
 
Bio g - ManufacturingIintelligence webinar GBX
byGBX Summits
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
byfinance40
 
C ph i biosimilar presentation - rahul padhye - reliance
byGenericlicensing.com
 
Ground Flour Pharma final NSF I-Corps presentation
byStanford University
 
"10th Contract Manufacturing for Pharmaceuticals and Biotech Conference
bycassie111
 
luxe research presentation at InnoCos Europe, Paris
byKGS Global
 

Similar to Drug Delivery Systems Americas (2011) Pp

PDF
Clinical Trial Logistics & Supply (2011) Fb
byFateja
 
PDF
Partnerships for Drug Delivery
bycassie111
 
PDF
2nd Prefilled Syringes Americas (2011) Pp
byKarnika Dawar
 
PDF
Amorphous Pharmaceutical Materials 2010
byPranita Nangia
 
PDF
2nd prefilled syringes americas (2011)
byPranita Nangia
 
PDF
5th Annual Product Lifecycle Management (2012) Pp
byPiyush Patel
 
PDF
4th Annual Pharmaceutical Plm (2010) Ta
bytatisalla
 
PDF
6th Annual Biosimilars 2010 (Usa)
bygbashe
 
PDF
EDT Newsletter Nov 2010
byElan Drug Technologies
 
PDF
6th Annual Biosimilars 2010 (Usa)
byConeyskuhl
 
PDF
11th Annual Biosimilars Uk (2012)
byshad121
 
PDF
7th Annual Biosimilars (2010)
byjaayboy69
 
PDF
5th Annual Stability Testing (2011) Pp
byPiyush Patel
 
PDF
5th Annual Pharmacovigilance (2010) Ts
bytatisalla
 
PDF
2nd Pharmaceutical Anti Counterfeiting Americas (2011) Pp
byPiyush Patel
 
PDF
4th Annual Contract Manufacturing (2010)
byjaayboy69
 
PDF
3rd Pre Filled Syringes (2010)
byjaayboy69
 
PDF
6th annual pharmacovigilance conference (2011)
byPranita Nangia
 
PDF
3rd Annual Packaging And Labelling Congress (2010) Ts
bytatisalla
 
PDF
3rd Annual Vaccine Manufacturing (2011) Pp
byPiyush Patel
 
Clinical Trial Logistics & Supply (2011) Fb
byFateja
 
Partnerships for Drug Delivery
bycassie111
 
2nd Prefilled Syringes Americas (2011) Pp
byKarnika Dawar
 
Amorphous Pharmaceutical Materials 2010
byPranita Nangia
 
2nd prefilled syringes americas (2011)
byPranita Nangia
 
5th Annual Product Lifecycle Management (2012) Pp
byPiyush Patel
 
4th Annual Pharmaceutical Plm (2010) Ta
bytatisalla
 
6th Annual Biosimilars 2010 (Usa)
bygbashe
 
EDT Newsletter Nov 2010
byElan Drug Technologies
 
6th Annual Biosimilars 2010 (Usa)
byConeyskuhl
 
11th Annual Biosimilars Uk (2012)
byshad121
 
7th Annual Biosimilars (2010)
byjaayboy69
 
5th Annual Stability Testing (2011) Pp
byPiyush Patel
 
5th Annual Pharmacovigilance (2010) Ts
bytatisalla
 
2nd Pharmaceutical Anti Counterfeiting Americas (2011) Pp
byPiyush Patel
 
4th Annual Contract Manufacturing (2010)
byjaayboy69
 
3rd Pre Filled Syringes (2010)
byjaayboy69
 
6th annual pharmacovigilance conference (2011)
byPranita Nangia
 
3rd Annual Packaging And Labelling Congress (2010) Ts
bytatisalla
 
3rd Annual Vaccine Manufacturing (2011) Pp
byPiyush Patel
 

More from Piyush Patel

PDF
2nd Annual Cell Based Assays (2011) Pp
byPiyush Patel
 
PDF
4th Annual Biomarkers (2011) Pp
byPiyush Patel
 
PDF
5th Annual Contract Manufacturing (2011) Pp
byPiyush Patel
 
PDF
5th Annual Recombinant Antibodies (2012) Pp
byPiyush Patel
 
PDF
7th Annual Pharmacovigilance (2012) Pp
byPiyush Patel
 
PDF
10th Annual Pricing & Reimbursement (2011) Pp
byPiyush Patel
 
PDF
9th Biosimilars (2011) Pp
byPiyush Patel
 
PDF
Clinical Trial Logistics & Supply (2011) Pp
byPiyush Patel
 
2nd Annual Cell Based Assays (2011) Pp
byPiyush Patel
 
4th Annual Biomarkers (2011) Pp
byPiyush Patel
 
5th Annual Contract Manufacturing (2011) Pp
byPiyush Patel
 
5th Annual Recombinant Antibodies (2012) Pp
byPiyush Patel
 
7th Annual Pharmacovigilance (2012) Pp
byPiyush Patel
 
10th Annual Pricing & Reimbursement (2011) Pp
byPiyush Patel
 
9th Biosimilars (2011) Pp
byPiyush Patel
 
Clinical Trial Logistics & Supply (2011) Pp
byPiyush Patel
 

Drug Delivery Systems Americas (2011) Pp

  • 1.
    CALL NOW FOR EARLY BIRD Drug Delivery Systems DISCOUNTS Americas 2011 Examining latest scientific research, manufacturing and commercial opportunities November 16th - 17th 2011, Boston, USA BOOK NOW! Key Speakers Anand Subramony, Principal Fellow & Head Novel Delivery Technologies & Therapeutics, Novartis Avinash G. Thombre, Research Fellow, Pfizer Bernhardt L. Trout, Director, Novartis-MIT Center for Continuous Manufacturing Danchen Gao, Director of Intellectual Property Strategy, Abbott Joseph Wong, Principal Scientist, Baxter Kathleen L. Hefferon, Professor, University of Toronto Lee Shorter, Director R&D Open Innovation, GlaxoSmithKline Niren Murthy, Associate Professor, Georgia Institute of Technology Oliver Steinbach, Senior Director, Head Bio-Molecular Engineering, Philips Corporate Technologies Otilia Koo, Senior Research Investigator, Drug Product Science & Technology, Bristol-Myers Squibb Peter Hoffmann, VP New Technology Development, Genzyme Riccardo Panicucci, Head of Chemical & Pharmaceutical Profiling, Novartis Saileta Prabhu, Scientist, Genetech Z. Jane Li, Senior. Research Fellow, Boehringer-Ingelheim Driving the Industry Forward | www.futurepharmaus.com Media Partners Organised By To Book Call: +44 (0) 20 7336 6100 | www.visiongain.com/ddsamericas
  • 2.
    Conference Introduction Drug Delivery Systems Americas November 16th - 17th 2011, Boston, USA Dear Colleague, orth $93.60bn in 20091, drug delivery technology and systems is one W Poster Presentation of the fastest growing markets in the pharmaceutical and biotechnology At a busy conference it is hard to make sure everyone who shares your interests knows what you are doing. sectors with almost 50% of the revenue generated from North America . 2 Maximise your time at Visiongain’s Biosimilars and Follow- This sector is expected to maintain double digit growth in the coming years On Biologics Americas meeting by sharing your results in a poster presentation. With a plethora of key decision makers, which will depend on new and innovative developments in drug delivery take advantage of this senior networking opportunity. technology that offer improved clinical advantages, patient comfort, Please send your 200 word abstract, in English, to: convenience and compliance. info@visiongainglobal.com for approval. The deadline for submissions is Friday, November 4th, 2011. Please rug Delivery Systems Americas 2011 - building on the success of our D include contact details for the corresponding author(s). previous six drug delivery conferences will bring together industry experts Academic institutions will not be charged a fee if booked as full-price delegates. Posters submitted by pharmaceutical from around the world to discuss the crucial issues and current trends and biotechnology firms will be charged a fee of £199 in drug delivery systems. This two day event will focus on various drug (USD $319*). formulations, delivery of lipids, proteins and peptides additionally exploring Posters submitted by service providers / vendors are welcome and will be subject to evaluation. Upon approval drug delivery commercial aspects, partnering and out-sourcing, key a fee of £500 (USD $801*) will apply. Two delegates from your organisation must be booked at full price to present regulatory and legal issues. a poster. Please note that all posters will be displayed at the Attendance at this conference will enable you to: discretion of Visiongain Ltd and are subject to approval. Due to limited space, please register your interest early. • vercome challenges and opportunities in the delivery of small molecules O • ain insight about protein and peptide drug delivery strategies for product G lifecycle management Who should attend this conference? • xplore innovations in generic development of drug delivery systems E VPs, Directors, Heads, Managers of: • Pharmaceutical Development • Discuss about enhancing the bioavailability of poorly soluble drugs • Drug Delivery • Delivery Device Development • Learn impact on product lifecycles: controlled-release technologies • Product Development • Analytical Chemistry • Evaluate niosomes as effective transdermal drug delivery systems • Pre-formulation • Project Management • Discover advances in oral transmucosal drug delivery • Technology Development • Drug Delivery Partnering • Stay ahead by learning latest on biologics delivery systems • Out-sourcing • In-Licensing • Identify different strategies in managing a drug delivery alliance • Technology Assessment • Lifecycle management • Examine PTD–DRBD siRNA Delivery • Strategic Planning and Development • Formulation/Stability • Obtain latest information on ultrasonic drug delivery • Business Development • Licensing • Create patient centered drug delivery product • Commercial Development • Patents • ind out information on regulations and current practices nasal drug products F • Lifecycle Management • Strategic Planning and Development • eview advanced technological and regulatory developments on QbD/PAT R • Financial Analyst in Pharmaceutical development • Pharmaceutical and Analytical R&D • Testing • revent aggregation in manufacturing and formulation of protein and P • New Product Planning • New Technology Evaluation peptide therapeutics • Marketing • Brand Management • btain the latest market analysis, and meet manufacturers showcasing O • Product Management • Sales their leading products • Regulatory Affairs I look forward to meeting you at the conference Others: • Intellectual Property Attorneys Best regards • Venture Capitalists • Medical Device Companies • Analysts/Investment Banks • CROs • Contract Sales Organisations • Universities and Government Research • Testing and Manufacturing Equipment Sonia Tomar • Packaging Companies Conference Producer *USD price is estimate only 1 visiongain’s Drug Delivery technologies: Commercial prospects 2010-2025 2 MarketsandMarkets: Top 10 Drug Delivery Technologies Market to be US$156 Billion by 2015
  • 3.
    Day 1 Drug Delivery Systems Americas Wednesday November 16th 2011 09:00 Registration and refreshments 14:20 Life-cycle management: development and manufacturing process considerations for fixed-dose 09:30 Opening address from the chair combination drug products • aterial powder and mechanical properties considerations that impact M 09:40 The magic bullets of the shots heard round the the processibility and quantity of fixed-dose combination products world targeted macromolecule delivery • echnologies to monitor process and product quality, as well as to T • Obtain overview of the option to deliver biologics to target manage risks • Stimulate use advanced drug delivery formulation for targeting • ontrol systems that can improve scale-up and manufacturing C • Enable macromolecules targeting to treat • Identify state of the art targeting delivery options Otilia Koo Senior Research Investigator, Drug Product Science & Technology Peter Hoffmann Bristol-Myers Squibb VP New Technology Development Genzyme Pharmaceuticals 15:00 Afternoon Refreshments 10:20 Emerging drug delivery technologies towards patient centric therapy 15:20 The mucosal response to plant-derived • Delivery of high volume biologics/antibodies: biopharmaceuticals • atch pumps devices as an emerging alternative to subcutaneous P • iopharmaceuticals can be produced quickly and inexpensively in plants B injections for the delivery of biologics • onsumption of vaccines proteins via edible plant tissues has been C • Use of mechanical and electromechanical systems demonstrated to effectively elicit a mucosal immune response • Creating patient centric drug delivery tools via user studies • lants have advantages as bioreactors because unlike bacterial systems, P • Microneedles and the trandermal interface they possess post-translational machinery, and unlike mammalian cell • Programmable drug delivery methods culture systems, they are free from infectious contaminants Anand Subramony Principal Fellow and Head • lant-derived biopharmaceuticals have enormous potential for assisting P Novartis vaccination programs in developing countries, for the prevention of global pandemics/ bioterrorism, and for applications in personalized medicine 11:00 Morning refreshments • number of plant derived biopharmaceuticals have completed clinical A trials and have now entered the global marketplace 11:20 Overcome challenges and opportunities in the Kathleen L. Hefferon Professor delivery of small molecules University of Toronto • Fundamentals of delivery of small molecules • Controlled release in delivery of proteins and nucleic acids • nalysing intestinal solubility and permeability and particle size to A 16:00 Addressing delivery of antibodies across the blood- overcome rate limited absorption brain barrier (BBB) Z. Jane Li • Overview of the transport barriers for antibodies in the brain Senior Research Fellow • Disposition of antibodies in the CNS Boehringer-Ingelheim • Leveraging receptor-mediated transcytosis for CNS delivery 12:00 Development and administration of intravenous Saileta Prabhu Scientist nanosuspension Genetech • here has been growing interest in nanoparticles as an approach to T formulate poorly soluble drugs • his presentation provides an insight into various challenges associated with T 16:40 Closing remarks from the chair developing and administrating intravenous nanosuspension including: • formulation approach of stabilizing nanosuspension A 16:50 Networking Drinks • article size and nanosuspension sterility considerations P Take your discussions further and build new • re-clinical disposition of a nanosuspension following IV administration P relationships in a relaxed and informal setting. • nfusion rates for nanosuspension I Joseph Wong Principal Scientist Baxter N EW Pharma Business Daily SL 12:40 Networking lunch E Each issue of Pharma Business Daily newsletter focuses on latest TT ER breaking stories in your market. Delivered directly to your Inbox or 13:40 Life cycle management through drug available through the website, all the industry news is available to delivery technologies you all the time. When you want the news its there for you - it really is that simple. Over 25+ stories everyday as they happen. Never again • Challenges and opportunities in life cycle management will any of your colleagues be aware of news that you aren’t. Plus • Product enhancement using drug delivery exclusive features from visiongain conferences and in-depth analysis • Platform controlled release technologies from visiongain analysts will be available to you thanks to your • Case studies and lessons learned subscription to PharmaBusinessDaily. This information is not available Avinash G. Thombre anywhere else. Research Fellow Call +44 (0)207 336 6100 or visit www.visiongain.com to sign up. Pfizer Due to unforeseen circumstances the programme may change and visiongain reserves the right to alter the venue and/or speakers c Copyright visiongain Ltd, 2011
  • 4.
    Day 2 Drug Delivery Systems Americas Thursday November 17th 2011 09:00 Registration and refreshments 12:40 Networking lunch 09:30 Opening address from the chair 13:40 Prevent aggregation in manufacturing and formula- tion of protein and peptide therapeutics • Techniques to predict aggregation propensity 09:40 New materials for drug delivery and • New approaches to preventing aggregation molecular imaging • A strategy for developability and manufacturability early on • Overview on new materials for drug delivery • Ways to design molecules for stability • Autocatalytic drug delivery vehincles Bernhardt L. Trout • Polyketals : a new biomaterial for drug delivery Director, Novartis-MIT Center for Continuous Manufacturing • Oral siRNA delivery vehicles Professor, Department of Chemical Engineering, Massachusetts Institute of Technology Niren Murthy Associate Professor Georgia Institute of Technology 14:10 Finding synergy in drug delivery through strategic outsourcing 10:20 IMAG(IN)E global - release local – Image-guided • The value of strategic outsourcing: decision drivers ultra sound-triggered drug delivery • From transactional to strategic • edical imaging technologies are becoming an integral part of M • Strategic outsourcing: what lies ahead therapeutic interventions Danchen Gao • he development of ultrasound techniques that could non-invasively T Director of Intellectual Property Strategy trigger the delivery of also very new drug formats such as RNAi Abbott therapeutics at a targeted location opens up exciting possibilities for advancing personalized medicine • key success factor for the effective translation of new drug delivery A 15:00 Afternoon refreshments concepts into clinical practice are partnerships with leading academic, medical institutions and industrial partners • hilips’ image-guided ultrasound-mediated drug delivery platform offers P 15:20 Open Innovation in preclinical development at researchers a unique approach to investigating the delivery of various GSK pharmaceuticals therapeutic molecules and capitalizes upon Philips’ existing expertise in medical imaging technologies for diagnosis, therapy planning and • What is open innovation? minimally-invasive medical procedures • hy is GSK using open innovation within the platform technology and W • e show advances in temperature sensitive liposomes with incorporated W Science group? drugs and MRI-imaging labels as well as pressure-sensitive microbubbles • Process GSK PTS is following for open innovation with specific ultrasound-imaging and drug release characteristics for the • Examples of successful open innovation collaborations local delivery of small molecule- and nucleic-acid based therapeutics including siRNA • How will success of open innovation be measured? Oliver Steinbach Lee Shorter Senior Director, Head Bio-Molecular Engineering Director R&D Open Innovation Philips Corporate Technologies GlaxoSmithKline 11:00 Morning refreshments 16:00 Patent and other Intellectual property rights in drug delivery • Advancements in drug delivery technology 11:20 Sponsor Spotlight Session • Patenting the technological advancements T ake this unique opportunity to be a part of the conference • Issues around manufacturing process patents theme, network, share ideas and provide an overview of your • ntellectual property protection, such as trade secrets, copyrights, I product/services to the audience. For more information please and trademarks contact damian.gorman@visiongainglobal.com 16:40 Chair’s closing remarks 12:00 Presentation to be announced Riccardo Panicucci Head of Chemical & Pharmaceutical Profiling 16:50 End of Conference Novartis
  • 5.
    Partners Drug Delivery Systems Americas November 16th - 17th 2011, Boston, USA Media Partners: PharmiWeb.com is the leading industry-sponsored Sponsorship and exhibition opportunities: portal for the pharmaceutical sector. Supported This event offers a unique opportunity to meet and do business by most of the leading pharmaceutical corporations, PharmiWeb. with some of the key players in the pharmaceutical and biotech com provides dynamic real-time news, features, events listings and international jobs to industry professionals across Europe and the US. industries. If you have a service or product to promote, you can For further information please email: corporate@pharmiweb.com do so at this event by: • Hosting a networking drinks reception BIOTECHNOLOGY EUROPE is owned by • Taking an exhibition space at the conference BIOTECHNOLOGY WORLD. It is based and located in Warsaw, Poland. Biotechnology World was founded in 2007 to • Advertising in the delegate documentation pack provide the world’s biotech and pharma information and market to • Providing branded bags, pens, gifts, etc. make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the If you would like more information on the range of BIOTECHNOLOGY EUROPE platform that will allow a quick spread of sponsorship or exhibition possibilities for visiongain's information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and Drug Delivery Systems Americas Conference, marketing solutions. One of the mains goals of BIOTECHNOLOGY please contact us. EUROPE is to integrate the Biotech and Pharma Sector in Europe to Damian Gorman, +44 (0)20 7549 9934 global biotechnology, pharmaceutical and life science activities. For further information please visit www.biotechnology-europe.com damian.gorman@visiongainglobal.com InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, jobs and events and is home to InPharmjobs.com, Pharmafile and About visiongain: Pharmafocus. Visiongain is a specialist business information company focused on For further information please visit: www.inpharm.com providing cutting edge products and services across the Pharmaceutical/ Biotech, Telecommunications, Defence and Finance sectors, which Future Pharmaceuticals has forged powerful Driving the Industry Forward | www.futurepharmaus.com include reports, conferences, online daily news and offline news relationships with key industry leaders to provide analysis and bespoke consultancy. With a commitment to innovation a platform for successful brand recognition, and for senior decision- and excellence, visiongain offers flexible solutions to meet our clients’ makers to have the means to procure and plan implementation business intelligence needs, providing the right information at the strategies based on the topics covered. Positioned to be an authoritative resource within top pharma companies as well as small, right time to facilitate the commercial decision-making process. Our specialty, and biotech, Future Pharmaceuticals magazine is geared pharmaceutical products include Pharma Business Daily, the leading to create a deep penetration into a highly targeted and responsive daily email newsletter for the pharmaceutical, biotech and healthcare audience, bridging the gap between the industries’ top issues and industries, and a range of independent, high-quality, in-depth reports the solutions top-tier vendors can provide. covering focused and topical areas of concern. Our pharmaceutical For further information please visit: www.futurepharmaus.com conferences address the hottest commercial, regulatory and technical topics and provide an ideal forum for debate and networking for pharmaceutical professionals from around the world. For further information, please visit: www.visiongain.com
  • 6.
    Registration Form Drug Delivery Systems Americas November 16th - 17th 2011, Boston, USA Conf. code PP Standard Prices Conference only Fee: £1299 (USD* 2081) Drug Delivery Systems Americas November 16th - 17th 2011 Number of bookings: Total cost: Boston, USA *USD price is estimate only Promotional Literature Distribution Distribution of your company’s promotional literature to all conference attendees Fee: £999 VAT: £199.80 Total: £1198.80 How to book Details Email: piyush.patel@visiongain.com Forename: Surname: Web: http://www.visiongain.com/ddsamericas UK Office: Job Title: Company: Tel: +44(0) 20 7549 9961 Fax: +44(0) 20 7549 9932 Main Switchboard Number: Visiongain Ltd 230 City Road London Address: EC1V 2QY UK General information Venue: TBA, Boston, USA Country: Postcode: Payment terms: Visiongain require the full amount to be paid before the conference. Visiongain Ltd may refuse entry to delegates who have not paid their invoice in full. A credit card guarantee Phone: Fax: may be requested if payment has not been received in full before the event. Visiongain Ltd reserves the right to charge interest on unpaid invoices. Email: Substitutions/name changes or cancellations: There is a 50% liability on all bookings once made, whether by post, fax, email or web. There is a no refund policy for cancellations received on or Signature: after one month before the start of the event. Should you decide to cancel after this date, the full invoice must be paid. Conference notes will then be sent to you. Unfortunately, we are unable to transfer places I confirm that I have read and agree to the terms and conditions of booking between conferences. However, if you cannot attend the conference, you may make a substitution/name change at any time, as long as we are informed in writing by email, fax or post. Name changes and substitutions must be from the same company or organisation and are not transferable between Methods of payment countries. Please note that discounted delegates places at a visiongain event are non refundable. Payment must be made in sterling Invoice alterations: There will be an administration charge of £50 for any changes to an invoice, excluding substitutions/name changes, requested by the customer. This will be charged to the By Mail: Complete and return your signed registration form together with your cheque payable customer by credit card prior to the changes being made. to Visiongain Ltd and send to: visiongain Ltd, BSG House, 226-236 City Road, London, EC1V 2QY, UK Indemnity: Visiongain Ltd reserves the right to make alterations to the conference/executive briefing content, timing, speakers or venue without notice. The event may be postponed or cancelled By Fax: Complete and fax your signed registration form with your credit card details due to unforeseen events beyond the control of visiongain Ltd. If such a situation arises, we will try to +44 (0) 20 7549 9932 to reschedule the event. However, visiongain Ltd cannot be held responsible for any cost, damage or expenses, which may be incurred by the customer as a consequence of the event being postponed or By Phone: Call us on +44 (0) 20 7336 6100 with your credit card details cancelled. We therefore strongly advise all our conference clients to take out insurance to cover the cost of the registration, travel and expenses. By Credit Card: Fill in your card details below and fax back to +44 (0) 20 7549 9932 Data Protection: Visiongain Ltd gathers and manages data in accordance with the Data By Bank Transfer: Protection Act 1988. Your personal information contained in this form may be used to update you on visiongain Ltd products and services via post, telephone, fax or email, unless you state otherwise. We Visiongain Ltd A/C: visiongain Ltd may also share your data with external companies offering complementary products or services. If you Barclays Bank Sort Code: 20-71-64 wish for your details to be amended, suppressed or not passed on to any external third party, please Piccadilly Branch Account No: 6038 7118 send your request to the Database Manager, visiongain Ltd, BSG House, 226-236 City Road, London, EC1V 2QY. Alternatively, you can visit our website at www.visiongain.com and amend your details. 48 Regent Street Swift Code: BARC GB22 Please allow approximately 30 days for your removal or update request to be applied to our database. London W1B 5RA, UK IBAN: GB80 BARC 20716460387118 Following your removal or update request, you may receive additional pieces of communication from visiongain Ltd during the transitional period, whilst the changes are coming into effect. Please debit my credit card: Fee: The conference fee includes lunch, refreshments and conference papers provided on the day. Access MasterCard Visa American Express This fee does not include travel, hotel accommodation, transfers or insurance, (which we strongly recommend you obtain). VAT: VAT will be charged at the local rate on each conference. Delegates may be able to recover VAT Card number: incurred by contacting Eurocash Corporation plc +44 (0) 1273 325000, eurocash@eurocashvat.com. Eurocash specialise in recovering cross-border VAT. How we will contact you: Visiongain Ltd’s preferred method of communication is by email and phone. Please ensure that you complete the registration form in full so that we can contact you. Expiry Date: Unable to attend Security number (last 3 digits on back of credit card): Obviously nothing compares to being there but you need not miss out. Simply tick the box and send with your payment. You will receive speaker talks in PDFs two weeks after the event. Signature: Yes, please send me speaker talks Price£550 VAT:£110 Total:£660 Cardholder’s name: Office use only News updates Please tick if you do not want to receive email news updates in the future www.visiongain.com/ddsamericas